Open AccessCost Analysis of Platelet Transfusion in Italy for Patients with Chronic Liver Disease and Associated Thrombocytopenia Undergoing Elective Procedures
Author(s) -
Giulia Mastrorilli,
Francesca Fiorentino,
Carmen Tucci,
Gloria Lombardi,
Alessio Aghemo,
Giorgio Lorenzo Colombo
Publication year - 2022
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s354470
Subject(s) - medicine , platelet transfusion , fresh frozen plasma , emergency medicine , total cost , indirect costs , intensive care medicine , blood transfusion , platelet , surgery , business , accounting , economics , microeconomics
Platelet transfusions (PT) are commonly used as prophylaxis in patients with chronic liver disease (CLD) and severe thrombocytopenia (TCP) before invasive procedures, in order to reduce risk of bleeding. The aim of this cost analysis was to generate a comprehensive estimate of costs of platelet transfusions in Italy, focusing on patients with severe TCP due to CLD undergoing an elective procedure.